Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Leave a Comment / By Market Social / March 4, 2026

The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.

Post navigation

Prediction market ‘gambling’ needs state regulation, not feds, Mick Mulvaney says after Iran war bets

Target says it’s on track to end its sales slump after another lackluster quarter

Your email address will not be published. Required fields are marked *

Comment *

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Markets

Trading

About Us

Name * Only alphabets are allowed.

Password

Again Password

Referral (Optional)

Support Language

Whatsapp Number *

OTP